Sign in to continue:

Wednesday, April 15th, 2026

AdaptHealth Corp. Files 8-K Announcing Credit Agreement and Financial Updates – April 2026





AdaptHealth Corp. Announces New Credit Agreement and Repayment of Prior Debt

AdaptHealth Corp. Announces New Credit Agreement and Full Repayment of Prior Debt

Date of Report: April 10, 2026
Filed: April 13, 2026
Ticker: AHCO
Exchange: Nasdaq Stock Market LLC

Key Highlights

  • New Credit Agreement Executed: AdaptHealth Corp. has entered into a new Credit Agreement as of April 10, 2026. The details of this agreement, including financial covenants and restrictions, are outlined in the company’s latest SEC filing.
  • Full Repayment and Termination of Prior Debt: On the same date, the company repaid in full all outstanding indebtedness under its prior credit agreement. All commitments, guarantees, liens, and security interests related to the prior facility have been terminated.
  • Funding for Repayment: The repayment was made using borrowings from the new Credit Agreement, indicating a refinancing move.
  • Customary Covenants and Financial Maintenance Requirements: The new Credit Agreement contains customary representations, warranties, and both affirmative and negative covenants, including strict financial maintenance covenants such as a required Consolidated Total Leverage Ratio not greater than 3.50 to 1.00 (or up to 4.00 to 1.00 under certain conditions).
  • Regulation FD Disclosure: On April 13, 2026, AdaptHealth issued a press release announcing the new Credit Agreement.

Details of the New Credit Agreement

The Credit Agreement introduces several important restrictions and requirements for AdaptHealth and its subsidiaries (“Loan Parties”), including:

  • Limitations on incurring additional indebtedness or guaranteeing others’ debts.
  • Restrictions on creating liens on properties or assets.
  • Limitations on making loans, advances, or other investments in other entities.
  • Restrictions on disposing of property and assets.
  • Limitations on making dividends, distributions, and payments or prepayments on certain unsecured or subordinated debt.
  • Financial maintenance covenants, specifically regarding leverage ratios as outlined above.

The full text of the Credit Agreement is available as Exhibit 10.1 to the filing, and is incorporated by reference in the Form 8-K.

Potential Shareholder Impact

  • Improved Financial Flexibility and Structure: The refinancing and execution of a new credit facility with updated terms may improve AdaptHealth’s financial position, potentially leading to lower interest expenses or more favorable debt covenants. This could have a positive impact on the company’s cash flow and earnings.
  • Balance Sheet Strengthening: The full repayment of the prior credit agreement and removal of related liens and guarantees could indicate increased lender confidence and a stronger balance sheet, which may be viewed positively by investors.
  • Ongoing Compliance Risks: The new covenants, especially the leverage ratio requirements, will require strict financial discipline. Any breach could have significant financial and reputational consequences.
  • Disclosure Not Deemed “Filed”: The press release attached as Exhibit 99.1 is furnished but not filed for purposes of Section 18 of the Exchange Act, and is not incorporated by reference into future filings under the Securities Act or Exchange Act. Investors should note that this limits the legal standing of those communications.

Other Noteworthy Information

  • Executive Signatory: The report is signed by Jason Clemens, Chief Financial Officer of AdaptHealth Corp., confirming the importance and executive oversight of this transaction.
  • Exhibits: The filing includes the full Credit Agreement (Exhibit 10.1) and the press release (Exhibit 99.1).

Investor Takeaway

The execution of a new Credit Agreement, full repayment of prior debt, and the removal of related liens and guarantees reflect significant steps by AdaptHealth to optimize its capital structure. These actions suggest proactive financial management and could enhance the company’s financial stability, making this a potentially price-sensitive development for shareholders and investors.


Disclaimer: This article is a summary and analysis based on AdaptHealth Corp.’s Form 8-K and related exhibits as filed with the SEC. It is intended for informational purposes only and does not constitute investment advice. Investors should review the full SEC filings and consult with financial advisors before making investment decisions.




View AdaptHealth Corp. Historical chart here



Douglas Emmett, Inc. Files Form 8-K Current Report with SEC – April 2026 Company Update

Douglas Emmett, Inc. Announces Director Retirement and Appoi...

Savara Inc. 2025 Annual Report: MOLBREEVI Clinical Progress, Business Strategy, and Key Risk Factors

Savara Inc. 2025 Annual Report – Investor Analysis Sav...

Leidos Completes $2.4 Billion Acquisition of ENTRUST Solutions Group, Doubling Energy Infrastructure Presence

Leidos Completes \$2.4 Billion Acquisition of ENTRUST Soluti...

   Ad